Predicting Treatment Outcomes in Head and Neck Cancer
Author Information
Author(s): Etienne M C, Pivot X, Formento J L, Bensadoun R J, Formento P, Dassonville O, Francoual M, Poissonnet G, Fontana X, Schneider M, Demard F, Milano G
Primary Institution: Centre Antoine Lacassagne
Hypothesis
The study aims to analyze the prognostic value of tumor markers in predicting treatment outcomes for head and neck cancer patients.
Conclusion
The study found that T staging and EGFR are independent predictors of survival in head and neck cancer patients receiving treatment.
Supporting Evidence
- Significant positive correlation was demonstrated between p53 and EGFR.
- In the RChem group, p53 was higher in non-complete responders than in complete responders.
- Survival increased when EGFR and p53 were below certain thresholds.
- T staging and EGFR were found to be independent predictors of survival.
Takeaway
Doctors can use certain tumor markers to help predict how well patients with head and neck cancer will respond to treatment.
Methodology
The study measured tumor markers in biopsies from patients and analyzed their correlation with treatment outcomes.
Participant Demographics
71 men and 11 women, mean age 59.
Statistical Information
P-Value
0.057
Statistical Significance
p=0.057
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website